We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-3.76%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$302M
AUM Growth
-$29.4M
(-8.9%)
Cap. Flow
-$9.85M
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
56.17%
Holding
86
New
16
Increased
11
Reduced
16
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$13.5M |
| 2 |
Sanofi
SNY
|
+$10.9M |
| 3 |
Inogen
INGN
|
+$9.8M |
| 4 |
Varex Imaging
VREX
|
+$8.02M |
| 5 |
Medpace
MEDP
|
+$4.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$17.3M |
| 2 |
SPDR Gold Trust
GLD
|
+$15.4M |
| 3 |
Cigna
CI
|
+$12.5M |
| 4 |
Herbalife
HLF
|
+$9.88M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$7.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 73.08% |
| 2 | Financials | 7.52% |
| 3 | Industrials | 0.43% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LITS
76
Lite Strategy Inc
LITS
$31.8M
| – | – |
-21,302
| Closed | -$1.14M |
|
|
MESO
77
Mesoblast
MESO
$2.04B
| – | – |
-13,330
| Closed | -$128K |
|
78
PUT
Neogen
NEOG
$2.46B
| – | – |
-25,100
| Closed | -$1.14M |
|
79
Organon & Co
OGN
$3.56B
| – | – |
-177,659
| Closed | -$5.41M |
|
80
Rigel Pharmaceuticals
RIGL
$739M
| – | – |
-91,362
| Closed | -$2.42M |
|
|
DCOY
81
Decoy Therapeutics
DCOY
$2.13M
| – | – |
-38
| Closed | -$671K |
|
82
Universal Health Services
UHS
$10.2B
| – | – |
-1,243
| Closed | -$161K |
|
|
BLU
83
PUT
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-181,800
| Closed | -$1.46M |
|
|
OYST
84
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| – | – |
-181,857
| Closed | -$3.32M |
|
|
ARNA
85
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – |
-42,379
| Closed | -$3.94M |
|
|
HZNP
86
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-29,319
| Closed | -$3.16M |
|
Similar funds
GUB
KLI
JA
AAM
TCM
CA
SAM
ACM
Sio Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Sio Capital Management held 86 positions worth $302M, down 8.9% from $332M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Sio Capital Management withdrew a net $9.85M in Q1 2022, closing 20 positions and reducing 16 holdings. Its most notable exit was Cardinal Health, an estimated $17.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 83% a quarter earlier, followed by Financials and Industrials.
Against the trend, Sio Capital Management opened a new position in Labcorp worth $13M.
- Sio Capital Management's largest Q1 2022 buy was Labcorp: 57,418 shares worth $13M.
- Sio Capital Management added most to Sanofi in Q1 2022, an estimated $10.9M increase.
- Sio Capital Management's biggest Q1 2022 reduction was Cigna, cutting an estimated $12.5M.
- Sio Capital Management fully exited Cardinal Health in Q1 2022, selling an estimated $17.3M.
- Sio Capital Management's ten largest holdings make up 56% of its $302M portfolio in Q1 2022.
- Sio Capital Management opened 16 new positions and closed 20 in Q1 2022.
- Sio Capital Management's portfolio value fell 8.9% quarter-over-quarter to $302M.
Based on Sio Capital Management's 13F filing for Q1 2022, filed 16 May 2022.